Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1995 | |
| Cash Flows From Operating Activities | |
| Net Income | 160 |
| Other Operating Activity | 50 |
| Operating Cash Flow | $210 |
| Cash Flows From Investing Activities | |
| Other Investing Activity | -150 |
| Investing Cash Flow | $-150 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | -150 |
| Financing Cash Flow | $-150 |
| Beginning Cash Position | 560 |
| End Cash Position | 470 |
| Net Cash Flow | $-90 |
| Free Cash Flow | |
| Operating Cash Flow | 210 |
| Free Cash Flow | 210 |